Some researchers have explored concurrent use of different GLP-1 agents , though this is less established in clinical practice
Some studies using highly specific radioligand assays found even lower rates or failed to detect receptors at all in normal human thyroid tissue
But as my mobility became more limited, I struggled to attend work events
51 In these studies, it has been reported that gallbladder stones and biliary tract diseases are more common in patients using GLP-1 RAs compared with placebo
[1] [3] In the UK, NICE recommends Wegovy as part of a specialist weight management service for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), with appropriate adjustments for people from Black, Asian and minority ethnic groups
The honest estimate from practitioners using this approach is that roughly 60 to 70% of patients see some degree of improvement, while 30 to 40% see no meaningful change